News
Adagio Medical Holdings, Inc. Receives FDA Breakthrough Device Designation for the vCLASTM Cryoablation System
-
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that it has received Breakthrough Device designation from the U.S. Food and Drug Administration (“FDA”) for its vCLASTM Cryoablation System for the treatment of drug-refractory, recurrent, sustained monomorphic ventricular tachycardia (“VT”) in patients with ischemic or non.04/17/2025
Adagio Medical Appoints Deborah Kaster as Chief Business Officer
-
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Adagio Medical (Nasdaq: ADGM), a leading innovator in catheter ablation technologies for treatment of cardiac arrhythmias, is pleased to announce the appointment of Deborah Kaster as Chief Business Officer (CBO). Kaster brings more than 25 years of leadership experience in strategy, mergers and acquisitions, corporate finance, investor relations and strategic communications in the medical technology sector. Most recently, Kaster served as Vice President of.03/31/2025
Profitability
Dividends
Income Statement
Balance Sheet
Cash Flow Statement
Symbol Frequently Asked Questions
Is Adagio Medical Holdings, Inc. (ADGM) a buy, sell, or hold?
Adagio Medical Holdings, Inc. (ADGM) can sell. Click on Rating Page for detail.
What is Adagio Medical Holdings, Inc.'s stock price?
The price of Adagio Medical Holdings, Inc. (ADGM) is 1.3 and it was updated on 2025-04-26 07:00:20.
Is Adagio Medical Holdings, Inc. (ADGM) overvalued or undervalued?
Currently Adagio Medical Holdings, Inc. (ADGM) is in undervalued.
News
| News |
|---|
 Adagio Medical Reports Fourth Quarter and Full Year 2024 Results
|
 Adagio Medical Provides Clinical and Business Updates
|
 Adagio Medical Announces Strategic Restructuring to Accelerate US Pivotal IDE Trial and Product Innovation
|
 Adagio Medical Announces Completion of First Procedures in FULCRUM-VT U.S. FDA Pivotal IDE of Ventricular Tachycardia Cryoablation System
|
 Adagio Medical Announces Participation in the 19th Annual International Symposium on Ventricular Arrhythmias
|
SEC Filings
Press Releases
| StockPrice Release |
|---|
ADGM Ratings Summary
ADGM Quant Ranking
